关注
Elisabeth Narayanan
Elisabeth Narayanan
其他姓名Elisabeth Humphris, Elisabeth Humphris-Narayanan
ReNAgade Therapeutics
在 renagadetx.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
KS Corbett, DK Edwards, SR Leist, OM Abiona, S Boyoglu-Barnum, ...
Nature 586 (7830), 567-571, 2020
14842020
Serum neutralizing activity elicited by mRNA-1273 vaccine
K Wu, AP Werner, M Koch, A Choi, E Narayanan, GBE Stewart-Jones, ...
New England Journal of Medicine 384 (15), 1468-1470, 2021
4812021
Role of toll-like receptors in changes in gene expression and NF-κB activation in mouse hepatocytes stimulated with lipopolysaccharide
S Liu, DJ Gallo, AM Green, DL Williams, X Gong, RA Shapiro, ...
Infection and immunity 70 (7), 3433-3442, 2002
3052002
A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
N Kose, JM Fox, G Sapparapu, R Bombardi, RN Tennekoon, AD De Silva, ...
Science immunology 4 (35), eaaw6647, 2019
1952019
RosettaBackrub—a web server for flexible backbone protein structure modeling and design
F Lauck, CA Smith, GF Friedland, EL Humphris, T Kortemme
Nucleic acids research 38 (suppl_2), W569-W575, 2010
1472010
Design of multi-specificity in protein interfaces
EL Humphris, T Kortemme
PLoS computational biology 3 (8), e164, 2007
1202007
A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
P Zhang, E Narayanan, Q Liu, Y Tsybovsky, K Boswell, S Ding, Z Hu, ...
Nature medicine 27 (12), 2234-2245, 2021
1002021
Prediction of protein-protein interface sequence diversity using flexible backbone computational protein design
EL Humphris, T Kortemme
Structure 16 (12), 1777-1788, 2008
1002008
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
K Wu, A Choi, M Koch, S Elbashir, LZ Ma, D Lee, A Woods, C Henry, ...
Vaccine, 2021
912021
Discovery of a novel amino lipid that improves lipid nanoparticle performance through specific interactions with mRNA
M Cornebise, E Narayanan, Y Xia, E Acosta, L Ci, H Koch, J Milton, ...
Advanced Functional Materials 32 (8), 2106727, 2022
552022
Salmonella vaccines
N Cohen, MAA Messou, S Calabrese, E Narayanan
US Patent App. 16/180,076, 2019
532019
Structural and mechanistic exploration of acid resistance: kinetic stability facilitates evolution of extremophilic behavior
BA Kelch, KP Eagen, FP Erciyas, EL Humphris, AR Thomason, S Mitsuiki, ...
Journal of molecular biology 368 (3), 870-883, 2007
512007
Epstein-barr virus vaccines
G Ciaramella, S John, E Narayanan, B Bollman
US Patent App. 16/765,285, 2020
402020
Rna bacterial vaccines
E Narayanan, N Cohen, G Ciaramella
US Patent App. 16/496,135, 2020
402020
Discrete RNA libraries from pseudo-torsional space
E Humphris-Narayanan, AM Pyle
Journal of molecular biology 421 (1), 6-26, 2012
342012
A new way to see RNA
KS Keating, EL Humphris, AM Pyle
Quarterly reviews of biophysics 44 (4), 433-466, 2011
292011
Chimeric fusion (F) and attachment (G) glycoprotein antigen delivery by mRNA as a candidate Nipah vaccine
RJ Loomis, AT DiPiazza, S Falcone, TJ Ruckwardt, KM Morabito, ...
Frontiers in Immunology 12, 772864, 2021
272021
Prediction of mutational tolerance in HIV-1 protease and reverse transcriptase using flexible backbone protein design
E Humphris-Narayanan, E Akiva, R Varela, S Ó Conchúir, T Kortemme
Public Library of Science 8 (8), e1002639, 2012
252012
Solving nucleic acid structures by molecular replacement: examples from group II intron studies
M Marcia, E Humphris-Narayanan, KS Keating, S Somarowthu, ...
Acta Crystallographica Section D: Biological Crystallography 69 (11), 2174-2185, 2013
212013
Hiv rna vaccines
P Lusso, P Zhang, E Narayanan, SM Elbashir
US Patent App. 17/439,198, 2022
122022
系统目前无法执行此操作,请稍后再试。
文章 1–20